April 25, 2011

There’s nothing like a recession for focusing merchants on what matters most. For USA Drug, that meant concentrating on core markets, cutting costs and recharging its image for down-home value, neighborly service and a broadly merchandised front end focused on local consumer preferences.


March 3, 2011

In a letter penned Thursday by the National Association of Chain Drug Stores to Sen. Olympia Snowe, R-Maine, the association stated that while it shares the goal of reducing prescription drug costs, authorizing the reimportation of prescription medications — as sought in S.319, the Pharmaceutical Market Access and Drug Safety Act of 2011 — raises concerns about patient health and safety.

December 23, 2010

Marsh Supermarkets recently implemented a $3.99/$9.99 generic drug pricing offer for 30-day and 90-day prescriptions, respectively.

November 9, 2010

Walgreens on Wednesday released a survey that found 2-in-5 American households have at least one...

November 8, 2010

The Consumer Healthcare Products Association recently relaunched its OTCsafety.org site, featuring new resources, content and...

September 2, 2010

Pfizer is pulling out of a development deal for a potential brain cancer drug, saying...

August 23, 2010

Drug advertisements that tie disease risks with family history can influence consumers' choice of medications...

July 5, 2010

Generic drug maker Caraco Pharmaceutical Labs has begun shipping a drug for treating dementia, Caraco...

June 22, 2010

Drug maker Cephalon has started a partnership with the American Chronic Pain Association and the...

May 3, 2010

The Food and Drug Administration on Tuesday announced through the Federal Register that a Sept....

March 14, 2010

Kinney Drugs plans to give its newest store a big opening, the regional retail pharmacy...

March 14, 2010

In keeping with its dual nature as both a franchise chain and a group of...

January 12, 2010

Prices of 416 branded drugs dramatically rose between 2000 and 2008, according to a recent...

November 10, 2008

The situation is like having plans to bake a loaf of bread for dinner, but discovering at 5 p.m. that the flour is running low, and there is little time to go to the supermarket to buy more. Generic drug makers depend on a steady supply of expiring patents coming from large pharmaceutical companies for their business. In recent years, a whole slew of blockbuster drugs have come off patent, allowing generic drug makers to lap up the drug compounds. Over the next several years, however, the supply of expiring patents will begin to run dry. Between this year and 2016, $131 billion worth of drugs will come off patent, followed by a long decline often called the patent cliff. Facing this precipice, generic drug companies will have to adapt as the market becomes increasingly commoditized.